fungi and insects (reviewed by Fiedler, 19931}) . The peptidyl side chain of these nikkomycins, 2-amino-4-hydroxy-3-methyl-4-(3/-hydroxy-6'-pyridyl)butanoic acid (hydroxypyridyl-homothreonine) ( Fig. 1) , is linked via a peptide bond to the nucleoside moiety. The nucleoside moiety consists of a 5-aminohexuronic acid with either 7V-glycosidically bound 4-formyl-l ,3-dihydro-2i/-imidazole-2-one (nikkomycin Cx; forming nikkomycin X) or TV-glycosidically bound uracil (nikkomycin Cz; forming nikkomycin Z). Nikkomycins I and J have glutamic acid peptidically bound to the 6/-carboxyl group of the nikkomycin Cx or Cz component, respectively. More than 20 biologically active nikkomycin structures have been generated by mutasynthesis, directed fermentation, and enzymatic modification, and have been isolated from mutants and as minor components from the culture filtrate of the wild type strain.
Here we report the isolation, structure elucidation, and antimicrobial activity of two novel nikkomycin derivatives, nikkomycins Lx and Lz, synthesized as main components by a genetically engineered mutant of S. tendae Tu901. The mutant was obtained by inserting a kanamycin resistance gene in the nikkomycin biosynthesis gene nikF encoding a cytochrome P450 monooxygenase (characterization and inactivation of the nikF gene will be separately published). To characterize the effect of the mutation on nikkomycin biosynthesis the nikF gene insertion mutant was cultivated in SP producpp. 582 -585 tion medium2) for seven days on a rotatory shaker at 27°C and the culture filtrate was analyzed for nikkomycins by HPLC3) and for antifungal activity against the test organism Paecilomyces variotii by agar diffusion assay. The mutant did not not synthesize nikkomycins Z, X, J, and I, which exhibit retention times of 6.95, 7.20, 8.80, and 8.90minutes, respectively, in HPLCchromatograms. In contrast, the mutant accumulated two compounds which eluted at 6.90 and 7.00 minutes. According to the high antifungal activity of culture filtrates and the following data they were expected to be novel nikkomycin derivatives that contain uracil or 4-formyl-imidazolone as the base, respectively, and were therefore named nikkomycins Lz and Lx. The UV/Vis diode-array spectral analyses indicated an absorption maximumat 260nm for nikkomycin Lz, and at 267nm and 286nm for nikkomycin Lx. The UV/Vis spectrum of nikkomycin Lz was almost identical to that of nikkomycins containing the uracil base4), and the spectrum of nikkomycin Lx was very similar to that of nikkomycin Kx5). Nikkomycin Kx contains 4-formyl-l ,3-dihydro-2/f-imidazole-2-one as the base and 2-amino-4-hydroxy-4-(2/-pyridyl)butanoic acid as the peptidyl moiety ( Fig. 1 Corporation; Tokyo) with water, and nikkomycin Lx was eluted with 10 % methanol, lyophilized and obtained at more than 95% purity.
The structures of nikkomycin Lx and Lz were elucidated by electrospray mass spectrometry and 1H-and 1 3C-NMRspectroscopy2).
ES . The deviations were below 1.5 ppm. However, fragments of the MS/MS experiments could not be unambigously assigned to the expected structure of nikkomycins Lx and Lz. The complete structure elucidation of nikkomycinLx was based on the following interpretation of NMR spectra (TOCSY, ROESY, HSQC, and HMBC)( Table   1 ). In the TOCSY spectrum, three spin systems were found; two spin systems were assigned to the aliphatic and aromatic part of the arylhomothreonine amino acid, and the third spin system was assigned to the sugar unit of the nucleoside. Because of the lack of a further spin system, which should have been observed if uracil were aNumbering of atoms see Figure 1 .
atom in the aromatic ring. The relative positions of the hydrogen atoms were finally assigned by three ROE contacts of neighboring protons, which points to an a-bound nitrogen, as also expected by comparison with the original structure of nikkomycin X. For a jS-bound nitrogen, only two ROE contacts would have been observed. Thus, the structure of nikkomycin Lx is identical to that ofnikkomycin X, except that the hydroxy group in the /^-position of the aryl-homothreonine is lacking.
The one-dimensional NMRspectrum of nikkomycin Lz revealed a pattern very similar to that of nikkomycin Lx. However, the corresponding signals from the formyl-imidazolone base were not detected, and two novel signals [(5(1H)=5.85ppm; 5(1H)=7.67ppm] that assign a uracil base were observed (data not shown).
Therefore, we concluded that nikkomycin Lz is an analogue of nikkomycin Lx that contains uracil instead of 4-formyl-l ,3-dihydro-2//-imidazole-2-one as the base (Fig.  1 ).
The stability of nikkomycins is influenced by the peptidyl moiety of the compounds2). Therefore, the stability of nikkomycins Lx and Lz was studied at various pH values using nikkomycins X and Z as references (Fig. 2) . Nikkomycins Lx and Lz were significantly more stable under alkaline condition than nikkomycins X and Z. Approximately 50% of both nikkomycins Lx and Lz was present after 28 days of incubation at pH 8.0, while nikkomycins X and Z were almost completely inactivated by hydrolysis of the peptide bond, yielding the peptidyl moiety, hydroxypyridylhomothreonine, and the nucleoside moieties, nikkomycins C¥ and CL Under neutral The antifungal activity of nikkomycin Lx and X were compared in agar diffusion assays5). The activity of nikkomycin Lx against various test organisms was slightly lower or similar to that of nikkomycin X5). MIC's have been not determined for nikkomycin Lz, as it was not purified to homogeneity. Biological activities similar to those described for nikkomycin Z would be expected7).
Synthesis ofnikkomycins Lx and Lz has been generated by molecular genetic manipulation of S. tendae TQ901 wild type. The peptidyl moiety of these nikkomycin derivatives, 2-amino-4-hydroxy-3-methyl-4-(2'-pyridyl)-butanoic acid (nikkomycin E) was previously isolated as a minor compound from the S. tendae T\i901 culture filtrate8 threonine, the peptidyl moiety of nikkomycins I, J, X, and Z. Nikkomycins Lx and Lz complete the series of nikkomycin derivatives that lack the hydroxy group at the pyridyl ring of the peptidyl moiety, i.e. nikkomycins Kx and Kz synthesized by a mutant obtained by chemical mutagenesis of the wild type5), and nikkomycins Px and Rx purified as minor components from the S. tendae Tii901 culture filtrate ( Fig. 1)8 ).
